Helsana Group (Switzerland)

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. University of Basel瑞士4
2. University of Freiburg德国2
3. University Hospital of Basel瑞士1
4. University of Zurich瑞士1
5. Klinik Hirslanden瑞士1
6. University of Southern Denmark丹麦1

按月发文

逐年被引

最新文献

1. 1
   Pharmacogenetic Testing in the Outpatient Setting in Switzerland: A Descriptive Study Using Swiss Claims DataDrug Safety20253
2. 2
   Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non‐melanoma Skin Cancer: An Interrupted Time‐Series Analysis Using Swiss Claims DataPharmacoepidemiology and Drug Safety20244
3. 3
   Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance databasePharmacoepidemiology and Drug Safety20192
4. 4
   Appropriateness of bone density measurement in Switzerland: a cross-sectional studyBMC Public Health20185
5. 5
   Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case–Control Analysis Based on Swiss Claims DataDrug Safety201820
6. 6
   Statin use and risk of cholecystectomy – A case-control analysis using Swiss claims dataExpert Opinion on Drug Safety201616
7. 7
   How does hospitalization affect continuity of drug therapy: an exploratory studyTherapeutics and Clinical Risk Management201628

高被引文献

1. 1
   How does hospitalization affect continuity of drug therapy: an exploratory studyTherapeutics and Clinical Risk Management201628
2. 2
   Glucocorticoids and the Risk of Peptic Ulcer Bleeding: Case–Control Analysis Based on Swiss Claims DataDrug Safety201820
3. 3
   Statin use and risk of cholecystectomy – A case-control analysis using Swiss claims dataExpert Opinion on Drug Safety201616
4. 4
   Appropriateness of bone density measurement in Switzerland: a cross-sectional studyBMC Public Health20185
5. 5
   Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non‐melanoma Skin Cancer: An Interrupted Time‐Series Analysis Using Swiss Claims DataPharmacoepidemiology and Drug Safety20244
6. 6
   Pharmacogenetic Testing in the Outpatient Setting in Switzerland: A Descriptive Study Using Swiss Claims DataDrug Safety20253
7. 7
   Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance databasePharmacoepidemiology and Drug Safety20192

主要发表期刊